UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients

What You Should Know:

  • BioIntelliSense, a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health, announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services. 
  • The transformational program leverages the BioIntelliSense FDA-cleared BioButton® wearable devices, algorithmic-based data analytics, and clinical intelligence system to monitor for subtle changes in vital sign trends and signs of potential patient deterioration for actionable clinical decisions and proactive interventions.

Revolutionising Patient Monitoring: BioIntelliSense at UC Davis Health

The BioButton, a medical-grade device, effortlessly records up to 1,440 sets of vital sign measurements per patient daily to monitor medical-surgical patients for potential complications after procedures. Positioned on the upper left chest, the multi-parameter BioButton securely gathers heart rate, respiratory rate, skin temperature trends, and various physiologic biometrics. Detecting clinically meaningful changes in vital signs, it provides an intuitive display of patient data and algorithmic-based notifications within the comprehensive BioIntelliSense clinical intelligence solution.

UC Davis Health, an acclaimed academic medical center, is at the forefront of digital transformation initiatives for equitable, accessible, and cost-effective patient care. Spearheaded by the UC Davis Health Digital CoLab, the BioIntelliSense project is driven by their dedication to identifying, evaluating, and implementing top-tier technologies and programs.

“Our first priority is to provide the best care experience possible, which is even more critical when dealing with our most vulnerable patients, who are at risk for changes in condition,” said Christine Williams, interim chief nursing and patient care services officer at UC Davis Health. “With the BioButton device and timely insights, our clinical teams can explore new innovations and solutions for continuously monitoring a patient’s health status.”